Accuray and UW-Madison Sign 10-Year Research Agreement for Adaptive Cancer Therapy

May 16, 2026
Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have entered a 10-year research agreement to develop personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform.

Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health have entered a 10-year research agreement to advance personalized cancer treatments using Accuray's Stellar adaptive radiation therapy platform, announced in a press release.

The collaboration will focus on clinical research, education, and the development of adaptive therapies that support precision cancer care. It formalizes a long-standing relationship between Accuray and the university, which began with the creation of the TomoTherapy System in the late 1980s. That system integrated helical 3D image guidance with intensity modulated radiation therapy, improving accuracy in treatment delivery.

According to the announcement, this new agreement will build on that history to develop future adaptive radiotherapy technologies and training programs aimed at improving patient outcomes and advancing clinical practice in radiation medicine.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/16
Anthropic and Gates Foundation Form $200 Million Partnership for Global Health, Education, and Economic Mobility
05/16
DCN and Partners Launch $700 Million Heartland Fiber Project Across Upper Midwest
05/16
OneStream and Microsoft Expand Partnership to Advance AI for Finance Teams
05/15
PacketFabric Expands Leadership and Engineering Teams to Meet AI Connectivity Demand
05/15
Blackstone Digital Infrastructure Trust Debuts on NYSE After $1.8 Billion IPO

More from: Life Sciences

05/16
United Imaging Presents Full Radiotherapy Portfolio at ESTRO 2026
05/16
Virtual Science AI Launches Competitor Tracking Platform for Pharma
05/15
Enlil Adds Eight MedTech Customers in Record First Quarter of 2026
05/15
Psynk AI Partners with Ocean View Psychiatric Hospital to Deploy AI Psychiatric Assistant
05/15
AI Screening for Childhood Blindness Begins in Mongolia

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like